Talis Biomedical Corp
NASDAQ:TLIS
Cash Flow Statement
Cash Flow Statement
Talis Biomedical Corp
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(45)
|
(55)
|
(91)
|
(144)
|
(199)
|
(208)
|
(192)
|
(165)
|
(127)
|
(115)
|
(113)
|
(98)
|
(86)
|
(75)
|
(62)
|
(57)
|
(51)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
6
|
9
|
9
|
8
|
4
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
2
|
3
|
4
|
5
|
6
|
8
|
9
|
9
|
8
|
7
|
5
|
5
|
5
|
5
|
4
|
4
|
3
|
|
| Other Non-Cash Items |
3
|
3
|
4
|
5
|
7
|
9
|
10
|
10
|
10
|
9
|
12
|
12
|
14
|
16
|
11
|
15
|
14
|
|
| Change in Working Capital |
(1)
|
(6)
|
(1)
|
34
|
65
|
31
|
9
|
(40)
|
(67)
|
(28)
|
(8)
|
5
|
(1)
|
0
|
(3)
|
(2)
|
(4)
|
|
| Cash from Operating Activities |
(42)
N/A
|
(56)
-34%
|
(87)
-55%
|
(104)
-19%
|
(125)
-21%
|
(167)
-33%
|
(171)
-2%
|
(193)
-12%
|
(181)
+6%
|
(127)
+30%
|
(100)
+21%
|
(73)
+27%
|
(65)
+11%
|
(55)
+15%
|
(53)
+4%
|
(43)
+19%
|
(40)
+7%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(1)
|
(6)
|
(8)
|
(9)
|
(9)
|
(4)
|
(3)
|
(3)
|
(2)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(6)
-550%
|
(8)
-38%
|
(9)
-7%
|
(9)
-2%
|
(4)
+52%
|
(3)
+33%
|
(3)
+7%
|
(2)
+8%
|
(3)
-4%
|
(2)
+37%
|
(1)
+30%
|
(1)
-25%
|
(1)
+56%
|
(0)
+23%
|
(0)
+11%
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
136
|
149
|
248
|
482
|
369
|
357
|
234
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
151
N/A
|
149
-1%
|
247
+65%
|
480
+95%
|
368
-23%
|
356
-3%
|
234
-34%
|
1
-99%
|
2
+57%
|
1
-46%
|
0
-62%
|
0
-69%
|
0
N/A
|
0
-74%
|
0
N/A
|
0
-94%
|
0
N/A
|
|
| Change in Cash | ||||||||||||||||||
| Net Change in Cash |
108
N/A
|
87
-20%
|
152
+74%
|
368
+143%
|
234
-36%
|
184
-21%
|
60
-67%
|
(194)
N/A
|
(182)
+6%
|
(129)
+29%
|
(101)
+21%
|
(74)
+27%
|
(66)
+10%
|
(56)
+16%
|
(54)
+4%
|
(44)
+19%
|
(40)
+8%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(43)
N/A
|
(62)
-45%
|
(95)
-53%
|
(113)
-18%
|
(134)
-19%
|
(172)
-28%
|
(174)
-2%
|
(195)
-12%
|
(184)
+6%
|
(130)
+29%
|
(102)
+22%
|
(74)
+27%
|
(67)
+10%
|
(56)
+16%
|
(54)
+4%
|
(44)
+19%
|
(40)
+8%
|
|